
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7489935
[patent_doc_number] => 20110237450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHODS AND SYSTEMS OF USING EXOSOMES FOR DETERMINING PHENOTYPES'
[patent_app_type] => utility
[patent_app_number] => 13/009393
[patent_app_country] => US
[patent_app_date] => 2011-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 149
[patent_figures_cnt] => 149
[patent_no_of_words] => 80474
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237450.pdf
[firstpage_image] =>[orig_patent_app_number] => 13009393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/009393 | Methods and systems of using exosomes for determining phenotypes | Jan 18, 2011 | Issued |
Array
(
[id] => 8270154
[patent_doc_number] => 08211653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Methods and systems of using exosomes for determining phenotypes'
[patent_app_type] => utility
[patent_app_number] => 13/009285
[patent_app_country] => US
[patent_app_date] => 2011-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 149
[patent_figures_cnt] => 79
[patent_no_of_words] => 80474
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009285
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/009285 | Methods and systems of using exosomes for determining phenotypes | Jan 18, 2011 | Issued |
Array
(
[id] => 8397926
[patent_doc_number] => 08268308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Means for the diagnosis and therapy of CTCL'
[patent_app_type] => utility
[patent_app_number] => 13/008406
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 20983
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13008406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008406 | Means for the diagnosis and therapy of CTCL | Jan 17, 2011 | Issued |
Array
(
[id] => 9662023
[patent_doc_number] => 08808997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Lung cancer markers, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/005031
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 55340
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005031 | Lung cancer markers, and uses thereof | Jan 11, 2011 | Issued |
Array
(
[id] => 8606081
[patent_doc_number] => 20130011393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'BAD PATHWAY GENE SIGNATURE'
[patent_app_type] => utility
[patent_app_number] => 13/519544
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 24577
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519544 | BAD PATHWAY GENE SIGNATURE | Jan 11, 2011 | Abandoned |
Array
(
[id] => 6047542
[patent_doc_number] => 20110207136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR'
[patent_app_type] => utility
[patent_app_number] => 13/005127
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11740
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207136.pdf
[firstpage_image] =>[orig_patent_app_number] => 13005127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005127 | Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR | Jan 11, 2011 | Abandoned |
Array
(
[id] => 8755249
[patent_doc_number] => 20130089554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'RON Binding Constructs and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/519675
[patent_app_country] => US
[patent_app_date] => 2010-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36362
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519675 | RON Binding Constructs and Methods of Use Thereof | Dec 28, 2010 | Abandoned |
Array
(
[id] => 8431029
[patent_doc_number] => 20120252904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'MITF AS A MARKER FOR PREDISPOSITION TO CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/515984
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8465
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515984 | MITF as a marker for predisposition to cancer | Dec 20, 2010 | Issued |
Array
(
[id] => 6038438
[patent_doc_number] => 20110091487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'MELANOMA BIOMARKER AND METHODS OF USES'
[patent_app_type] => utility
[patent_app_number] => 12/971106
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16041
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091487.pdf
[firstpage_image] =>[orig_patent_app_number] => 12971106
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/971106 | MELANOMA BIOMARKER AND METHODS OF USES | Dec 16, 2010 | Abandoned |
Array
(
[id] => 6125367
[patent_doc_number] => 20110086022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Methods for diagnosing and treating neuroendocrine cancer'
[patent_app_type] => utility
[patent_app_number] => 12/962177
[patent_app_country] => US
[patent_app_date] => 2010-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13688
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12962177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962177 | Methods for diagnosing and treating neuroendocrine cancer | Dec 6, 2010 | Issued |
Array
(
[id] => 6142221
[patent_doc_number] => 20110129482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/952593
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 106
[patent_figures_cnt] => 106
[patent_no_of_words] => 40173
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/952593 | POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH | Nov 22, 2010 | Abandoned |
Array
(
[id] => 8916890
[patent_doc_number] => 20130178515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'PREDICTIVE MARKERS FOR TAXANE RESPONSIVENESS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/510799
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10856
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510799
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/510799 | Predictive markers for taxane responsiveness and methods of use thereof | Nov 18, 2010 | Issued |
Array
(
[id] => 9389045
[patent_doc_number] => 08685640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Medical methods and agents for use therein'
[patent_app_type] => utility
[patent_app_number] => 13/510565
[patent_app_country] => US
[patent_app_date] => 2010-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 11
[patent_no_of_words] => 14936
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510565
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/510565 | Medical methods and agents for use therein | Nov 16, 2010 | Issued |
Array
(
[id] => 6080072
[patent_doc_number] => 20110142828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'TREATMENT PREDICTION INVOLVING HMGCR'
[patent_app_type] => utility
[patent_app_number] => 12/946934
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32076
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12946934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/946934 | Treatment prediction involving HMGCR | Nov 15, 2010 | Issued |
Array
(
[id] => 6111282
[patent_doc_number] => 20110189711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'PAAD DOMAIN-CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/942975
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35841
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12942975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/942975 | PAAD DOMAIN-CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE | Nov 8, 2010 | Abandoned |
Array
(
[id] => 11232030
[patent_doc_number] => 09459254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Method for determining sensitivity to an anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 13/505143
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9101
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 555
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505143
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505143 | Method for determining sensitivity to an anticancer agent | Oct 28, 2010 | Issued |
Array
(
[id] => 6070156
[patent_doc_number] => 20110045006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'LUCA2 and Antibodies That Bind Thereto'
[patent_app_type] => utility
[patent_app_number] => 12/915842
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24328
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12915842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/915842 | LUCA2 and Antibodies That Bind Thereto | Oct 28, 2010 | Abandoned |
Array
(
[id] => 7575701
[patent_doc_number] => 20110271357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'COLON DISEASE TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/911617
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42396
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20110271357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12911617
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/911617 | COLON DISEASE TARGETS AND USES THEREOF | Oct 24, 2010 | Abandoned |
Array
(
[id] => 6040913
[patent_doc_number] => 20110093962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'BREAST DISEASE TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/910390
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20110093962.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910390
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910390 | BREAST DISEASE TARGETS AND USES THEREOF | Oct 21, 2010 | Abandoned |
Array
(
[id] => 6063051
[patent_doc_number] => 20110201012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSING EPITHELIAL CELL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/907370
[patent_app_country] => US
[patent_app_date] => 2010-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19025
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201012.pdf
[firstpage_image] =>[orig_patent_app_number] => 12907370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/907370 | METHODS AND COMPOSITIONS FOR DIAGNOSING EPITHELIAL CELL CANCER | Oct 18, 2010 | Abandoned |